As of 28 Mai 2020, more than 5 593 631 cases of confirmed COVID-19 have been documented globally with over 353 334 deaths.
[1]. We reported previously a computational modeling drug design for a category of HIV drugs called non-nucleoside reverse
transcriptase inhibitor (NNRTI), nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs), respectively
[2&3]. Following these publications, Youssef et al. published recently other article describe the computational structural analysis
and drug combination of a series of HIV drugs namely; Abacavir, Lamivudine and Zidovudine towards drug for coronavirus
disease-19 (COVID-19
